Join me in recognizing Warrior Care Month, an important Department-wide effort to increase awareness of programs and resources available to wounded, ill, and injured Service members, as well as their families, caregivers, and others who support them. Established in 2008, the annual Warrior Care Month recognition occurs each November. The theme of this ...

Policy Memorandum to Establish 2022 Premium Rates for TRICARE Reserve Select, TRICARE Retired Reserve, TRICARE Young Adult, and the Continued Health Care Benefit Program

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Handout that accompanies the DHA Policy Memorandum about the COVID-19 Medical Coding Policy; updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

This memorandum updates reimbursement rates for medical services funded by the Military Departments (MLLDEPs) and provided at Department of Defense (DOD) deployed/nonfixed medical facilities to foreign nationals covered under Acquisition and Cross-Servicing Agreements (ACSAs).

Memorandum to DHA employees about the Reasonable Accommodation for Individuals with Disabilities Policy

Memorandum to DHA employees about the Right to File a Complaint of Discrimination Policy.

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

This memorandum contains DOD UBO FY 2021 Direct Care Inpatient Billing Rates, effective Oct. 1, 2020.

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Upon transfer, the Director, DHA, will assume responsibility for ensuring all Armed Services Blood Program (ASBP) activities are FDA-compliant.